Furthermore, elevated CRABP2 expression has been linked to a poorer prognosis and more advanced stages of endometrial cancer (EC), making it a valuable biomarker for identifying high-risk EC cases 32. The gene discussed is CRABP2; the disease is endometrial cancer.